tiprankstipranks
TipRanksTop Financial ExpertsInsidersDov Goldstein

Dov Goldstein Insider Profile

11 Followers
Dov Goldstein, Director at Gain Therapeutics, holds ― shares in Gain Therapeutics (Ticker: GANX), holds 36.58K shares in BioAge Labs, Inc. (Ticker: BIOA), holds 27.56K shares in Coya Therapeutics, Inc. (Ticker: COYA). Most recently, Dov Goldstein ― shares of Gain Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Dov Goldstein

Dov Goldstein
Gain Therapeutics (GANX)
Director

Ranked #16,492 out of 108,921 Corporate Insiders

Profitable Transactions

64%
7 out of 11 Profitable Transactions

Average Return

+10.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$542K
63.37%
23.43%
13.20%
0.00%
A breakdown of Dov Goldstein's holdings
See the Top Stocks by Insiders

Insider Roles

BioAge Labs, Inc.
(BIOA)
CFO
Coya Therapeutics, Inc.
(COYA)
Director
ADMA Biologics
(ADMA)
Director
Gain Therapeutics
(GANX)
Director
Roles that Dov Goldstein holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Loxo Oncology
(LOXO)
Rating:Informative Buy
Date:Apr 03, 2015 - Apr 03, 2016
Return:+137.50%
The most profitable trade made by Dov Goldstein
See the Latest Stocks Traded by Insiders

Dov Goldstein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GANX
Gain Therapeutics
―
Director
―
―
COYA
Coya Therapeutics, Inc.
Aug 19, 2025
Director
Uninformative Buy
19.14K
$127.04K
BIOA
BioAge Labs, Inc.
Apr 24, 2026
CFO
Uninformative Buy
15.51K
$343.62K
NBSE
NeuBase Therapeutics
Jun 21, 2021
―
Informative Buy
38.00K
$11.34K
LOXO
Loxo Oncology
Apr 03, 2015
―
Informative Buy
278.60K
$825.62M
MLNTQ
Melinta Therapeutics
Mar 09, 2017
―
Informative Sell
532.00K
$241.25K
ESPR
Esperion
Jun 08, 2018
―
Uninformative Buy
214.10K
$149.46
ADMA
ADMA Biologics
Mar 03, 2020
Director
Uninformative Buy
―
$71.55K
DRTX
Durata
Jul 25, 2012
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Dov Goldstein's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Dov Goldstein insider profile FAQ

What is the percentage of profitable transactions made by Dov Goldstein?
The percentage of profitable transactions made by Dov Goldstein is 64%.
    What is the average return per transaction made by Dov Goldstein?
    The average return per transaction made by Dov Goldstein is 10.70%.
      What stocks does Dov Goldstein hold?
      Dov Goldstein holds: GANX, COYA, BIOA, NBSE, LOXO, MLNTQ, ESPR, ADMA, DRTX stocks.
        What was Dov Goldstein’s latest transaction?
        Dov Goldstein latest transaction was an Uninformative Buy of ―.
          What was Dov Goldstein's most profitable transaction?
          Dov Goldstein’s most profitable transaction was an Informative Buy of LOXO stock on April 3, 2015. The return on the trade was 137.50%.
            What is Dov Goldstein's role in Gain Therapeutics?
            Dov Goldstein's role in Gain Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.